Page 1
doi:10.1182/blood-2006-05-024406Prepublished online July 6, 2006;
Mahesh Yadav and Jeffrey S Schorey macrophage activation by mycobacteria
-glucan receptor Dectin-1 functions together with TLR2 to mediatedβThe
(1930 articles)Signal Transduction � (974 articles)Phagocytes �
Articles on similar topics can be found in the following Blood collections
http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requestsInformation about reproducing this article in parts or in its entirety may be found online at:
http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprintsInformation about ordering reprints may be found online at:
http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtmlInformation about subscriptions and ASH membership may be found online at:
digital object identifier (DOIs) and date of initial publication. theindexed by PubMed from initial publication. Citations to Advance online articles must include
final publication). Advance online articles are citable and establish publication priority; they areappeared in the paper journal (edited, typeset versions may be posted when available prior to Advance online articles have been peer reviewed and accepted for publication but have not yet
Copyright 2011 by The American Society of Hematology; all rights reserved.20036.the American Society of Hematology, 2021 L St, NW, Suite 900, Washington DC Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 2
1
The β-glucan receptor Dectin-1 functions together with TLR2 to mediated macrophage activation by mycobacteria
Mahesh Yadav and Jeffrey S. Schorey
Department of Biological Sciences, Center for Tropical Disease Research and Training
University of Notre Dame, Notre Dame, Indiana, 46556
Corresponding author. Mailing address: Department of Biology, University of Notre Dame, 130 Galvin Life Science Center, Notre Dame, Indiana, 46556.
Phone: (574) 631-3734. Fax: (574) 631-7413.
E-mails: [email protected]
Running title: Dectin-1 and mycobacterial infection
Note: This work was supported through grants AI056979 and AI052439 from the
National Institute of Allergy and Infectious Diseases.
Scientific Heading: Phagocytes
Word count. Abstract (200 words) Total (4,862)
Blood First Edition Paper, prepublished online July 6, 2006; DOI 10.1182/blood-2006-05-024406
Copyright © 2006 American Society of Hematology
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 3
2
ABSTRACT
Pattern recognition receptors (PRRs) play an essential role in a macrophage’s response to
mycobacterial infections. However, how these receptors work in concert to promote this
macrophage response remains unclear. In this study, we used bone marrow-derived
macrophages isolated from Mannose Receptor (MR), Complement Receptor 3 (CR3),
MyD88, Toll-like receptor 4 (TLR4) and TLR2 knockout mice to examine the
significance of these receptors in mediating a macrophage’s response to a mycobacterial
infection. We determined that MAPK activation and TNF-α production in macrophage
infected with M. avium or M. smegmatis is dependent on MyD88 and TLR2 but not
TLR4, MR or CR3. Interestingly, the TLR2 mediated production of TNF-α by
macrophages infected with M. smegmatis required the β-glucan receptor Dectin-1. A
similar requirement for Dectin-1 in TNF-α production was observed for macrophages
infected with M. bovis BCG, M. phlei, M. avium 2151-rough and M. tuberculosis H37Ra.
The limited production of TNF-α by virulent M. avium 724 and M. tuberculosis H37Rv
was not dependent on Dectin-1. Furthermore, Dectin-1 facilitated IL-6, RANTES and G-
CSF production by mycobacteria-infected macrophages. These are the first results to
establish a significant role for Dectin-1, in cooperation with TLR2, to activate a
macrophage’s pro-inflammatory response to a mycobacterial infection.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 4
3
INTRODUCTION
The immune system has the complex task of separating “friend” from “foe”. To
accomplish this mission the immune system has evolved receptors which recognize
molecules present on pathogenic organisms but which show limited interaction with host
components. These receptors referred to as pattern recognition receptors (PRRs),
function to promote an innate immune response and include such members as the
mannose receptor, scavenger receptors and Toll-like receptors among others. PRRs bind
to conserved microbial structures called pathogen associated molecular patterns
(PAMPs). The expression of these receptors allows the immune system to recognize a
wide variety of pathogens which express one or more of these PAMPs and their
engagement initiates the subsequent immune response. Not surprisingly, the PRRs are
expressed on cells of the innate immune system including macrophages, neutrophils,
dendritic cells and NK cells 1.
Binding of microbial products by PRRs elicits a signaling response within the
leukocyte resulting in the production of specific immune modulators. Which PRRs are
engaged and in what combination, along with the specific ligands involved will dictate
the overall response by the immune cell. This complexity allows the immune system to
tailor its response to a specific pathogen, yet remain flexible enough to recognize a large
number of potential pathogens.
One of the most intensively studied PRR is the mannose receptor (MR) which has
been implicated in pathogen recognition through binding terminal mannose, fucose, and
N-acetylglucosamine residues 2,3. The major ligand for MR on mycobacterial surface is
the mannose-capped lipoarabinomannan (ManLAM) from M. tuberculosis and M. bovis
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 5
4
BCG 4-6.Another important group of PRRs are the Toll-like receptors (TLRs) which are
also involved in the innate recognition of mycobacteria by the host 7. After ligand
binding, TLRs activate signal transduction pathways by recruiting adaptor molecules
including myeloid differentiation factor 88 (MyD88) 8,9. Stimulation of TLRs by
microbial products activates NF-κB, MAPK and phosphoinositide 3-kinase signaling
pathways leading to activation of inflammatory target genes 10. In vitro studies have
shown a number of potent agonists on mycobacteria for TLR2 11,12 and TLR4 13,14, and
their role in controlling a mycobacterial infection 15,16. TLRs participate with additional
receptors in the innate recognition of microbes, and there is a strong interaction between
the signaling pathways induced by these receptors and signal transduction stimulated by
TLRs (for review 17,18). Dectin-1 is one of the receptors recently shown to complement
TLR signaling in order to generate a pro-inflammatory response 19. Dectin-1 is a C-type
lectin receptor expressed on monocytes, macrophages, neutrophils, Dendritic cells and
Langerhans cells which recognizes fungal wall-derived β-glucans 20,21. Dectin-1 promotes
the phagocytosis of live yeast and fungal-derived zymosan particles, as well as promotes
zymosan or fungal pathogen-induced pro-inflammatory response by macrophages and at
least in some cases cooperates with TLR2 to mediate this response 19,22. Recent studies
have also shown a role for Dectin-1 in the phagocytosis of Haemophilus influenzae by
eosinophils 23. However, the importance of Dectin-1 as a PRR and its role in promoting a
pro-inflammatory response to a mycobacterial infection or to bacterial infections in
general remains undefined.
In the present study we assessed the role of various macrophage PRRs in MAPK
activation and cytokine production upon mycobacterial infection. We found TLR2 and
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 6
5
Dectin-1 to work in concert to promote macrophage activation upon mycobacterial
infection. These are the first studies to indicate a role for Dectin-1 in promoting a
macrophage pro-inflammatory response to a mycobacteria infection.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 7
6
MATERIALS AND METHODS
Reagents Unless stated otherwise, all chemical reagents were purchased from Sigma (St.
Louis, MO).
Mice Balb/c and C57BL/6 mice were purchased from Harlan (Mutant Mouse Regional
Resource Center, Indiana). TLR2-/- and TLR4-/- mice were purchased from Jackson
Laboratory (Maine, USA). MyD88-/- (in C57BL/6 background) and CR3-/- (in Balb/c
background) were generously provided by Soon-Cheol Hong, Indiana University Medical
School and Tanya Mayadas-Norton, Harvard Medical College respectively. MR-/- and
C57BL/6 MR+/+ were kindly provided by Michel Nussenzweig, Rockefeller University.
Bacteria Mycobacteria stocks were generated by using a single colony to inoculate
Middlebrooks 7H9 media (Difco, Sparks, MD) supplemented with glucose, oleic acid,
albumin, Tween-20 and NaCl (GOATS). For Mycobacterium avium 724 stocks, the
mycobacteria were passaged through a mouse to ensure virulence. Bacteria were grown
for 3-10 days at 37°C with vigorous shaking, centrifuged, re-suspended in
Middlebrooks/GOATS plus 15% glycerol, aliquoted and stored at -80°C. Frozen stocks
were quantitated by serial dilution onto Middlebrooks 7H10 agar/GOATS. M. smegmatis
strain MC2155, M. bovis BCG, M. phlei, M. tuberculosis H37Rv, M. tuberculosis H37Ra
(ATCC) and other M. avium strains were cultured and frozen stocks prepared as
described above. All reagents used to grow mycobacteria were found negative for
endotoxin contamination using the E-Toxate assay and the QCL-1000 Endotoxin test
(Cambrex Bio Science, Walkersville, MD).
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 8
7
Complement opsonization Appropriate concentrations of mycobacteria were suspended
in macrophage culture media containing 10% horse serum as a source of complement
components and incubated for 2 hours at 37°C 29. The same concentration of horse serum
was added to uninfected controls for all experiments.
Bone marrow macrophage isolation and Mycobacteria infection BMMφs, used in all
experiments, were isolated from 6-8 week old mice as previously described 24. Infection
assays evaluated by fluorescence microscopy were performed on each stock of
mycobacteria to determine the infection ratio needed to obtain approximately 80% of the
macrophages infected. The MOI required to obtain 80% infection varied from
approximately 20:1 to 50:1 mycobacteria to macrophage and depended on the
mycobacterial species and frozen stock of mycobacteria. Briefly, BMMφs from WT or
KO mice were plated on glass coverslips and infected with different doses of
mycobacteria in triplicate. Infections were halted at either 1 hour or 4 hour and fixed in
1:1 methanol: acetone, washed with PBS, and stained with TB Auramine M Stain Kit
(Becton Dickinson, Sparks,MD) in the case of M. avium and M. bovis BCG, and with
acridine orange (Sigma) in case of M. smegmatis and M. phlei. Slides were visualized
using fluorescent microscopy and the level of infection was quantitated by counting the
number of cells infected and the approximate number of mycobacteria/cell in at least four
fields per replicate. No fewer than 100 cells per replicate were counted.
For all experiments, mycobacteria were added to macrophages on ice and
incubated for 10 minutes and then incubated at 37°C in 5% CO2 for the specified times.
Culture media without antibiotics or L-cell supernatant was used in place of complete
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 9
8
media during the infections. For the 24 hour time-points, the BMMφs were incubated for
4 hours with the mycobacteria, washed with PBS 3 times, then fresh media was added
and incubated for an additional 20 hours. All tissue culture reagents were found negative
for endotoxin contamination using either the E-Toxate assay.
Antibody treatment The anti-Dectin-1 antibody clone 2A11 and rat IgG2b isotype control
were purchased from Serotec (Oxford, UK). BMMφs were pre-incubated with 50µg/ml
2A11 or isotype control 1 hour prior to infection in DMEM and then infected with
mycobacteria. After 4 hour incubation, media was removed and cells were washed with
PBS three times and fresh media was added and incubated for an additional 20 hours.
Western blot analysis Blots were performed as previously described 24. Briefly, at
designated times, culture media was collected and saved for subsequent ELISAs and the
cells were washed 3 times with ice-cold PBS containing 1mM per-vanadate. The cells
were then treated for 5-10 minutes with ice-cold lysis buffer and the cell lysates were
removed from the plates and stored at -20°C. Equal amounts of protein, as defined using
the Micro BCA Protein Assay (Pierce, Rockford, IL), were loaded onto 10% SDS-PAGE
gels, electrophoresed and transferred onto PVDF membrane (Millipore, Bedford, MA).
The membranes were incubated with primary antibodies phospho-p38, total p38,
phospho-ERK1/2 or total ERK1/2 from Cell Signaling (Beverly, MA). The blots were
washed and incubated with a secondary antibody, either horseradish peroxidase
conjugated anti-rabbit or anti-mouse IgG (Pierce) in TBST plus 5% powdered milk. The
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 10
9
bound antibodies were detected using SuperSignal West Femto enhanced
chemiluminescence reagents (Pierce).
Cytokine measurements The levels of cytokines secreted by infected macrophages were
measured using the commercially available ELISA reagent kits for TNF-α (PharMingen,
San Diego, CA), IL-6, RANTES (eBioscience, San Diego, CA) and G-CSF (R&D
Systems, Minneapolis, MN). Culture media collected from the macrophages was
analyzed for cytokines according to manufacturers, instructions and the cytokine
concentrations were determined against standard curves. A cytokine profile analysis was
performed by using the RayBioTM Mouse Cytokine Array (RayBiotech Inc. Atlanta, GA)
with culture supernates from non-infected or infected macrophages.
Statistical analysis Statistical significance was determined with the paired two-tailed
Student’s t-test at P<0.05 level of significance, using InStat/Prism software.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 11
10
RESULTS
MR is not required for phagocytosis of M. avium or M. smegmatis by murine
macrophages.
Prior studies have indicated a role for the MR on human alveolar macrophages in
the phagocytosis of non-opsonized virulent Mycobacterium tuberculosis strains H37Rv
and Erdman but a minimal role in the phagocytosis of the avirulent strain H37Ra 25. With
the availability of mice deficient in the MR, we compared mouse bone marrow-derived
macrophages (BMMφs) from WT and MR-/- mice in their ingestion of complement-
opsonized and non-opsonized M. avium. We found a direct correlation between the
multiplicity of infection (MOI) and the percentage of cells infected; however, there was
no difference in the number of infected cells between WT and MR-/- macrophages at
either 1 or 4 hour infections (Fig 1). Moreover, we did not observe any detectable
differences in the number of mycobacteria per infected macrophage (data not shown). As
expected, we observed a higher number of infected BMMφs, when M. avium was
complement-opsonized compared to non-opsonized at both time points and at different
MOIs. Similar results were seen with non-pathogenic M. smegmatis, as we observed no
difference in its phagocytosis by WT and MR-/- BMMφs at 1 or 4 hour (data not shown).
BMMφs from TLR4-/-, TLR2-/- and MyD88-/- displayed no difference compared to WT
BMMφs in the uptake of complement-opsonized or non-opsonized mycobacteria (data
not shown).
MR, CR3 and TLR4 are not required for MAPK activation or TNF-α production
by BMMφs in response to M. avium or M. smegmatis infection.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 12
11
In addition to serving as phagocytic receptors, PRRs function to promote
macrophage activation characterized by production of cytokines, chemokines and oxygen
and nitrogen reactive species. This macrophage activation requires stimulation of
signaling pathways resulting in a transcriptional response. Activation of the mitogen
activated protein kinase (MAPK) pathways in macrophages has been associated with
PRR stimulation resulting in the production of numerous pro-inflammatory molecules 26-
28. To start addressing the role of various PRRs in promoting macrophage activation, we
first evaluated the signaling response by WT and MR-/- macrophages to infection with
pathogenic M. avium and non-pathogenic M. smegmatis. Specifically, BMMφs from WT
and MR-/- mice were infected with mycobacteria for 1 hour or 9 hour and MAPK
activation was measured by Western blotting for phospho-p38 and phospho-ERK1/2. We
chose to look at 1 and 9 hours, since our previous studies have shown an initial activation
of macrophage MAPKs by all mycobacteria, but a differential activation of MAPKs 9
hours post-infection in macrophages infected with non-pathogenic mycobacteria
compared to M. avium 24,29,30. As shown previously, MAPKs are activated upon
mycobacterial infection and macrophages infected with M. smegmatis show higher levels
of MAPK activation at 9 hours compared to non-infected BMMφs or M. avium infected
cells (Fig. 2A). However, there was no difference in MAPK activation between WT and
MR-/- macrophages following infection with either M. smegmatis or M. avium 724.
Previously we demonstrated the importance of the MAPKs, as well as other signaling
molecules involved in macrophage’s production of TNF-α following a mycobacterial
infection 24,29. Therefore, we looked at the TNF-α production in WT and MR-/- BMMφs
infected with M. smegmatis or M. avium 724. Similar to what we observed with MAPK
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 13
12
activation, there was no difference in TNF-α secretion between WT and the KO
macrophages (Fig 2B). Moreover, infection using non-opsonized mycobacteria also
showed similar levels of TNF-α in WT and MR-/- macrophages (Fig. 2B). As previously
observed, M. smegmatis infected macrophages produce significantly higher levels of
TNF-α relative to M. avium infected cells 24.
BMMφs from WT and TLR4-/- mice also showed no difference in MAPK
activation upon infection with either Mycobacterium (Fig 2C). Moreover, TNF-α
production induced upon infection with either M. smegmatis or M. avium 724 did not
differ between TLR4-/- and WT macrophages (Fig. 2D). To test the role of CR3 in the
macrophage response to a mycobacterial infection, we infected BMMφs from WT and
CR3-/- mice. As expected, BMMφs from CR3-/- mice showed decreased phagocytosis of
complement-opsonized mycobacteria, and required a higher mycobacteria to macrophage
ratio in order to obtain a similar infection level as WT macrophages (data not shown).
However, there was no difference in MAPK activation or TNF-α production upon
infection with complement opsonized or non-opsonized mycobacteria in CR3-/-
macrophages compared to WT (data not shown).
Optimal MAPK activation and TNF-α production by mycobacteria infected
macrophages requires TLR2 and MyD88.
The above data did not support a role for the MR, CR3 or TLR4 in the activation
of macrophages by M. avium or non-pathogenic M. smegmatis. To determine if the
observed BMMφ’s response to M. avium and M. smegmatis was dependent on TLR2, we
infected TLR2-/- and WT BMMφs with the different mycobacteria. BMMφs from TLR2-/-
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 14
13
mice showed a lack of MAPK activation above non-infected controls following an M.
avium 724 infection at both 1 and 9 hours post-infection (Fig. 3A). The low amount of
TNF-α produced by M. avium 724 infected BMMφs was also completely lost in TLR2-/-
BMMφs (Fig. 3B). In macrophages infected with M. smegmatis, no difference in ERK1/2
activation was observed between TLR2-/- and WT macrophages at 1 hour post-infection,
but by 9 hours a significant decrease in MAPK activation was discerned in the TLR2-/-
BMMφs (Fig. 3B). Furthermore, we observed a significant drop but not a complete loss
of TNF-α production in M. smegmatis infected TLR2-/- macrophages (Fig. 3B). The
adaptor protein MyD88 has been shown previously to be critical in TLR signaling 31. To
determine if MAPK activation and TNF-α production was dependent on MyD88, we
infected BMMφs from WT and MyD88-/- mice. Upon infection there was a complete loss
of MAPK activation in MyD88-/- macrophages. As shown in Fig. 3C, this effect was
evident at both 1 and 9 hours post-infection. Similarly there was no TNF-α production
detected in MyD88-/- macrophages upon infection with either M. smegmatis or M. avium
724 (Fig. 3D). These findings differ from our results with the TLR2-/- BMMφs, where
there was no loss in ERK1/2 phosphorylation at 1 hour post-infection and some TNF-α
production in M. smegmatis infected BMMφs.
Induction of TNF-α production upon mycobacterial infection is partially dependent
on Dectin-1.
We anticipated that TLR2 and MyD88 were required, at least in part, for the
mycobacteria-initiated macrophage activation, and our data supports this prediction.
However, TLR2 often functions in concert with other receptors including additional
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 15
14
TLRs and non-TLRs to promote cellular activation 17,18. Which combination of receptors
are engaged depends on the ligands involved 32. Dectin-1 is a recently described receptor
expressed on BMMφs 33, which can function together with TLR2 to induce macrophage
activation 19,22.
Dectin-1, a C-type lectin receptor, has been implicated in the innate recognition of
yeasts through its binding to surface β-glucan 34. Recently it has been found to cooperate
with TLR2 in eliciting inflammatory responses to Zymosan 19. Therefore, we were
interested in defining whether Dectin-1 plays a role in TNF-α production upon infection
with mycobacteria. For this purpose we utilized a previously characterized neutralizing
antibody against Dectin-1 33 to block the mycobacterial interaction with the macrophage
Dectin-1 receptor. Pre-treating the macrophages with the anti-Dectin-1 mAb 2A11 had no
affect on the phagocytosis of M. avium or M. smegmatis (data not shown). However, pre-
treating the macrophages with the 2A11 mAb resulted in a significant reduction in TNF-
α production upon infection with M. smegmatis (Fig. 4A). M. avium 724 induces little
TNF-α production and thus the effect of 2A11 was difficult to determine. Therefore, we
used the avirulent M. avium 2151 rough strain which is known to induce significant TNF-
α production 35. Like our findings with M. smegmatis, the production of TNF-α by M.
avium 2151 infected BMMφs was significantly blocked in the presences of anti-Dectin-1
mAb 2A11 (Fig. 4A). Similar reduction in TNF-α secretion upon M. smegmatis
infection was seen in macrophages pretreated for 1 hour with 700 µg/ml Laminarin, a
soluble β-glucan used for blocking the β-glucan receptor (Fig. 4B) 36. Pretreatment with
the polysaccharide Galactan at the same concentration did not affect TNF-α production
in M. smegmatis infected macrophages. Blocking Dectin-1 in BMMφs infected with non-
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 16
15
opsonized M. smegmatis also resulted in inhibition of TNF-α production (Fig. 4C).
However, there was no difference in TNF-α production in BMMφs treated with LPS in
the presence of 2A11 (Fig. 4C).
Dectin-1 mediated induction of TNF-α is dependent on TLR2 expression.
Recent papers have suggested a possible cooperation between TLR2 and Dectin-1
in zymosan recognition by HEK 293 cells. Gantner et al., showed that NF-κB activation
in macrophages by Zymosan requires both TLR2 and Dectin-1 19. We hypothesized that
there is a similar cooperation between Dectin-1 and TLR2 in macrophages infected with
mycobacteria. As shown earlier, there was a marked diminished TNF-α production in
TLR2-/- macrophages compared to WT upon infection with M. smegmatis (Fig. 5).
However in contrast to WT, pretreatment of TLR2-/- BMMφs with 2A11 did not further
reduce TNF-α production upon infection with M. smegmatis, suggesting that Dectin-1
mediated induction of TNF-α production was dependent on TLR2 (Fig. 5). No TNF-α
was detected in TLR2-/- BMMφs upon M. avium 724 infection (Fig. 5).
Dectin-1 facilitates TNF-α production in macrophages infected with M. phlei, M.
bovis BCG and M. tuberculosis H37Ra but not H37Rv.
To determine whether the importance of Dectin-1 in mediating macrophage
activation is limited to the avirulent M. avium 2151 rough strain and M. smegmatis, we
infected BMMφs with non-pathogenic M. phlei, attenuated M. bovis BCG, avirulent M.
tuberculosis H37Ra and virulent H37Rv. We measured infected BMMφs for TNF-α
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 17
16
production in the presence of 2A11 or isotype control antibody. As observed previously,
macrophages infected with M. phlei or M. bovis BCG induce high levels of TNF-α
production 24. However, this TNF-α production was reduced significantly in the presence
of the 2A11 antibody while no block was observed with the isotype control antibody
(Fig. 6A). Moreover, we observed significantly higher levels of TNF-α secreted by M.
tuberculosis H37Ra compared to H37Rv infected BMMφs, as observed previously 37.
The TNF-α produced by H37Ra but not H37Rv infected BMMφs was also significantly
decreased in cells treated with the 2A11 blocking antibody compared to untreated or
isotype control (Fig. 6B).
Dectin-1 promotes production of inflammatory mediators in addition to TNF-α in
mycobacteria infected macrophages.
To determine if the importance of Dectin-1 is limited to TNF-α production, we
measured the levels of other pro-inflammatory mediators in the presence of the Dectin-1
blocking antibody. We found that in addition to TNF-α, 2A11 significantly blocked the
BMMφ production of IL-6, G-CSF and RANTES following an M. smegmatis or M. bovis
BCG infection (Fig. 7A). A similar 2A11 antibody-mediated block in IL-6, RANTES
and G-CSF production was observed for BMMφs infected with M. avium 2151 rough or
M. tuberculosis H37Ra (Fig. 7B and data not shown). Infection of BMMφs with M.
avium 724 or H37Rv did not lead to significant levels of IL-6 or G-CSF in culture
supernatants (Fig. 7B and data not shown). However, RANTES production was
increased in M. avium 724 infected BMMφs and this was significantly reduced in 2A11
treated cells (Fig. 7B). Production of the different mediators was not affected by the
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 18
17
isotype control antibody. Together, our data indicates that Dectin-1 promotes the
macrophage’s ability to produce a broad spectrum of pro-inflammatory mediators upon
mycobacterial infection.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 19
18
DISCUSSION
The tailored reaction by macrophages to pathogenic organisms as well as their
response to host cell debris and apoptotic cells is dependent on the combination of
macrophage receptors engaged which together initiate a specific signaling response. Key
to understanding macrophage biology requires a definition of the macrophage receptors,
their ligands, the signaling reactions induced upon receptor engagement and the
consequence of their activation (e.g. production of pro-inflammatory mediators). In this
report we focused on a number of macrophage receptors including CR3, MR, TLR2,
TLR4 and Dectin-1 which have been characterized as phagocytic and/or signaling
receptors in the context of various infection models. The purpose of the present study
was to better understand how these receptors are involved in eliciting a macrophage
response following an infection with pathogenic and non-pathogenic mycobacteria.
The mannose receptor has been well studied and reported to bind a wide variety
of pathogens including Candida albicans 38, Leishmania donovani 39, Pneuomcystis
carinii 40 and M. tuberculosis 25. It has been shown to bind Mannose capped LAM (Man-
LAM) from pathogenic but not the phosphoinositol capped LAM from non-pathogenic
mycobacteria 6 and was revealed to mediate phagocytosis of pathogenic M. tuberculosis.
However, we observed that the MR was not necessary for the phagocytosis of
complement opsonized or non-opsonized M. avium 724 or M. smegmatis. The observed
differences in mannose receptor’s role in the present study (using murine BMMφs) and
prior studies (using primary human alveolar macrophages) may in part reflect differences
in the expression and function of the MR, or the redundancy of other phagocytic
receptors in murine macrophages relative to human macrophages. In addition, the MR on
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 20
19
human macrophages was shown to bind terminal mannnosyl residues of LAM 5,6 and
studies by Khoo et al., indicate a terminal mono-mannosylation of M. avium Man-LAMs
compared to a di-mannosylation of Man-LAM in M. tuberculosis 41. MR on human
macrophages was also shown to be involved in the phagocytosis of M. smegmatis 42.
However, we observed no difference in the uptake of M. smegmatis between murine WT
and MR-/- BMMφ (data not shown). Similarly, there was no difference in TNF-α
production between WT and MR-/- BMMφs upon infection with mycobacteria. Therefore
our data does not support a role for the MR in MAPK activation or TNF-α production
upon mycobacterial infection of mouse BMMφs. However, we cannot rule out the
contribution of the MR in the activation of other macrophage signaling pathways upon
mycobacterial infection or in MAPK activation upon stimulation with other MR ligands.
The Toll-like receptors have also been extensively characterized in the context of
mycobacterial infections through both in vitro and in vivo studies 7,43. Studies by Feng et
al., indicated that MyD88, and to a lesser extent TLR2, deficient mice were highly
susceptible to an M. avium infection. However, TLR4-/- mice were comparable to WT in
controlling an M. avium infection 16. This is in agreement with in vitro studies which
indicate that M. avium can stimulate a response through TLR2 but not TLR4 44. The M.
avium ligand for TLR2 has recently been defined as glycopeptidolipids (Sweet, L and
Schorey, J.S. J. Leukocyte Biology, In press). This finding contrasts with M.
tuberculosis, which can engage both TLR2 through the 19 KDa lipoprotein and PIM 45,46
and TLR4 through heat shock protein 65 47. Non-pathogenic mycobacteria like M.
smegmatis also express ligands for both TLR2 and TLR4 but whether whole bacteria can
activate both receptors has not been defined. At least in the context of MAPK activation
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 21
20
and TNF-α production, we failed to observe a role for TLR4 in a macrophage response to
a M. smegmatis infection.
In contrast, we have observed that both M. smegmatis and M. avium infected
macrophages require TLR2 and MyD88 for macrophage activation. The adaptor
molecule MyD88 is critical for TLR2 signaling and for signaling by other Toll-like
receptors, although TLR4 can signal through a MyD88 independent manner as well 9,31.
It is interesting that the early MAPK activation and some TNF-α production by M.
smegmatis infected BMMφs was independent of TLR2, but required MyD88 suggesting
that M. smegmatis can engage other TLRs to initiate the signaling response. This was not
the case for M. avium whose MAPK activation and TNF-α production was completely
dependent on TLR2. Our results are consistent with previously published in vitro studies
indicating that of the Toll-like receptors; only TLR2 is stimulated by M. avium 16.
Nevertheless our present data demonstrate that TLR2 is vital for an optimal
macrophage response to infection by both pathogenic and non-pathogenic mycobacteria.
A recent study showed that TLR2 associates with Ras to activate ERK1/2 and
TRAF6/TAK1 to activate p38 upon infection with M. avium 48. Further experimentation
is needed to define how the signaling complexes associated with TLR2 differ in
macrophages infected with pathogenic versus non-pathogenic mycobacteria. However,
TLR2 often dimerizes with other Toll-like receptors such as TLR1 and TLR6 following
ligand engagement 49,50. The signaling responses initiated will likely depend on which
combinations of Toll-like receptors are engaged.
Recent studies indicate that TLR2 can also function in concert with receptors
other then TLRs. Of the various receptors which can function in conjunction with TLRs
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 22
21
to stimulate a cellular response, we focused our attention on the pattern recognition
receptor Dectin-1. Dectin-1 is a type II C-type lectin receptor which is expressed on
monocytes, macrophages, neutrophils, DCs and Langerhans cells. Dectin-1 binds to β-
glucans and has been implicated in eliciting an inflammatory response to zymosan and
other yeast 21,51. Gantner et al showed that Dectin-1 cooperates with TLR2 to induce NF-
κB activation and TNF-α production upon zymosan treatment 19. Another recent study
showed that Dectin-1 could interact with TLR2 during a fungal infection to stimulate
TNF-α and IL-6 secretion by macrophages 22. However, it is unclear whether Dectin-1
functions in stimulating a macrophage response to organisms other then yeast. Using the
neutralizing monoclonal antibody 2A11 to block Dectin-1, we observed this PRR to
promote macrophage production of TNF-α, RANTES, IL-6 and G-CSF in cells infected
with a number of different mycobacteria including non-pathogenic M. smegmatis and M.
phlei, attenuated M. bovis BCG and avirulent M. avium 2151 rough and M. tuberculosis
H37Ra. However, questions remain as to the importance of Dectin-1 in mediating a
macrophage signaling response to pathogenic mycobacteria. The limited release of TNF-
α, G-CSF and IL-6 by M. avium 724 and M. tuberculosis H37Rv infected BMMφs makes
it difficult to define a role for Dectin-1 in the production of these mediators.
Nevertheless, the release of RANTES, which is markedly increased in M. avium 724
infected BMMφs, is significantly diminished in cells treated with the blocking anti-
Dectin-1 antibody. This suggests that Dectin-1 may play a more restricted role in a
BMMφ’s signaling response to pathogenic mycobacteria. It is intriguing to speculate that
limited engagement/stimulation of Dectin-1 by pathogenic mycobacteria is responsible, at
least in part, for the minimal macrophage pro-inflammatory response induced by these
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 23
22
mycobacteria. Our data also indicates that TLR2 is required for the Dectin-1 mediated
pro-inflammatory response since there was no change in TNF-α production in TLR2-/-
BMMφs infected with M. smegmatis in the presence or absence of blocking antibody
2A11.
There have been recent reports that ligation of Dectin-1 results in tyrosine
phosphorylation of the receptor’s ITAM signaling motif leading to recruitment of the
tyrosine kinase Syk and initiation of the downstream signaling response. For example,
Dectin-1 engagement by yeast can stimulate IL-2 and IL-10 production in a Syk kinase
dependent but TLR2 independent mechanism 52. Moreover, in a subset of macrophages,
Dectin-1 mediated production of reactive oxygen species was dependent on Syk kinases
53. The exact mechanism by which Dectin-1 promotes a TLR2 pro-inflammatory
response to mycobacteria is unclear but it might function through an effect on NF-κB.
Future studies will address this important issue and whether Syk kinases are involved.
What ligand(s) on mycobacteria interact with Dectin-1? At present this question
remains unanswered. BCG and M. tuberculosis express α-glucan within the outer
capsule 54,55. In contrast, the presence of β-glucan has not been described in
mycobacteria. Nevertheless, M. tuberculosis binding to the lectin binding site on CR3
was inhibited by the β-glucan Laminarin 56. However, this may simply indicate that the
CR3 lectin site can bind multiple carbohydrates including α and β glucans. Dectin-1 has
also been described to bind an endogenous but undefined ligand on T cells 57, indicating
that Dectin-1 has the potential to bind molecules other then β-glucans. Additional studies
will be needed to define the Dectin-1 ligand on mycobacteria.
To our knowledge a role for the pattern recognition receptor Dectin-1 in
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 24
23
stimulating a macrophage response has not been demonstrated for any bacterial pathogen.
Our data suggest that Dectin-1 serves to amplify the TLR2 dependent activation of a
macrophage’s pro-inflammatory response to non-pathogenic and to a lesser extent
pathogenic mycobacteria. Therefore, Dectin-1 may play a significant role in promoting
an immune response against a mycobacterial infection by facilitating macrophage
activation. A test of this hypothesis awaits in vivo studies in Dectin-1 deficient mice.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 25
24
ACKNOWLEDGEMENTS: This work was supported through grants AI056979 and
AI052439 from the National Institute of Allergy and Infectious Diseases. We gratefully
received the M. tuberculosis H37Rv from Colorado State University as part of NIH,
NIAID Contract No. HHSN266200400091C, entitled "Tuberculosis Vaccine Testing and
Research Materials”.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 26
25
REFERENCES
1. Gordon S. Pattern recognition receptors: doubling up for the innate immune
response. Cell. 2002;111:927-930.
2. Lennartz MR, Cole FS, Shepherd VL, Wileman TE, Stahl PD. Isolation and
characterization of a mannose-specific endocytosis receptor from human placenta. J Biol
Chem. 1987;262:9942-9944.
3. Wileman TE, Lennartz MR, Stahl PD. Identification of the macrophage mannose
receptor as a 175-kDa membrane protein. Proc Natl Acad Sci U S A. 1986;83:2501-2505.
4. Venisse A, Fournie JJ, Puzo G. Mannosylated lipoarabinomannan interacts with
phagocytes. Eur J Biochem. 1995;231:440-447.
5. Schlesinger LS, Hull SR, Kaufman TM. Binding of the terminal mannosyl units of
lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human
macrophages. J Immunol. Vol. 152; 1994:4070-4079.
6. Schlesinger LS, Kaufman TM, Iyer S, Hull SR, Marchiando LK. Differences in
mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated
strains of Mycobacterium tuberculosis by human macrophages. J Immunol.
1996;157:4568-4575.
7. Quesniaux V, Fremond C, Jacobs M, et al. Toll-like receptor pathways in the
immune responses to mycobacteria. Microbes Infect. 2004;6:946-959.
8. Akira S, Yamamoto M, Takeda K. Role of adapters in Toll-like receptor signalling.
Biochem Soc Trans. 2003;31:637-642.
9. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-
deficient mice to endotoxin. Immunity. 1999;11:115-122.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 27
26
10. Takeuchi O, Akira S. Toll-like receptors; their physiological role and signal
transduction system. Int Immunopharmacol. 2001;1:625-635.
11. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates
mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci U
S A. 1999;96:14459-14463.
12. Jones BW, Means TK, Heldwein KA, et al. Different Toll-like receptor agonists
induce distinct macrophage responses. J Leukoc Biol. 2001;69:1036-1044.
13. Means TK, Jones BW, Schromm AB, et al. Differential effects of a Toll-like
receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J
Immunol. 2001;166:4074-4082.
14. Abel B, Thieblemont N, Quesniaux VJ, et al. Toll-like receptor 4 expression is
required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol.
2002;169:3155-3162.
15. Reiling N, Holscher C, Fehrenbach A, et al. Cutting edge: Toll-like receptor
(TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection
with Mycobacterium tuberculosis. J Immunol. 2002;169:3480-3484.
16. Feng CG, Scanga CA, Collazo-Custodio CM, et al. Mice lacking myeloid
differentiation factor 88 display profound defects in host resistance and immune
responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2
(TLR2)- and TLR4-deficient animals. J Immunol. 2003;171:4758-4764.
17. Underhill DM. Toll-like receptors: networking for success. Eur J Immunol.
2003;33:1767-1775.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 28
27
18. Mukhopadhyay S, Herre J, Brown GD, Gordon S. The potential for Toll-like
receptors to collaborate with other innate immune receptors. Immunology. 2004;112:521-
530.
19. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative
induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med.
2003;197:1107-1117.
20. Taylor PR, Brown GD, Reid DM, et al. The beta-glucan receptor, dectin-1, is
predominantly expressed on the surface of cells of the monocyte/macrophage and
neutrophil lineages. J Immunol. 2002;169:3876-3882.
21. Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of beta-
glucans by macrophages. Mol Immunol. 2004;40:869-876.
22. Viriyakosol S, Fierer J, Brown GD, Kirkland TN. Innate immunity to the
pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and
Dectin-1. Infect Immun. 2005;73:1553-1560.
23. Ahren IL, Williams DL, Rice PJ, Forsgren A, Riesbeck K. The importance of a
beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into
human monocytic and epithelial cells. J Infect Dis. 2001;184:150-158.
24. Roach SK, Schorey JS. Differential regulation of the mitogen-activated protein
kinases by pathogenic and nonpathogenic mycobacteria. Infect Immun. 2002;70:3040-
3052.
25. Schlesinger LS. Macrophage phagocytosis of virulent but not attenuated strains of
Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement
receptors. J Immunol. 1993;150:2920-2930.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 29
28
26. Grewal T, de Diego I, Kirchhoff MF, et al. High density lipoprotein-induced
signaling of the MAPK pathway involves scavenger receptor type BI-mediated activation
of Ras. J Biol Chem. 2003;278:16478-16481.
27. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell
Signal. 2001;13:85-94.
28. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-
stranded RNA and activation of NF-kappaB by Toll-likereceptor 3. Nature.
2001;413:732-738.
29. Yadav M, Roach SK, Schorey JS. Increased mitogen-activated protein kinase
activity and TNF-alpha production associated with Mycobacterium smegmatis- but not
Mycobacterium avium-infected macrophages requires prolonged stimulation of the
calmodulin/calmodulin kinase and cyclic AMP/protein kinase A pathways. J Immunol.
2004;172:5588-5597.
30. Roach SK, Lee SB, Schorey JS. Differential activation of the transcription factor
cyclic AMP response element binding protein (CREB) in macrophages following
infection with pathogenic and nonpathogenic mycobacteria and role for CREB in tumor
necrosis factor alpha production. Infect Immun. 2005;73:514-522.
31. Akira S, Hoshino K. Myeloid differentiation factor 88-dependent and -independent
pathways in toll-like receptor signaling. J Infect Dis. 2003;187 Suppl 2:S356-363.
32. Wetzler LM. The role of Toll-like receptor 2 in microbial disease and immunity.
Vaccine. 2003;21:S55-60.
33. Brown GD, Taylor PR, Reid DM, et al. Dectin-1 is a major beta-glucan receptor on
macrophages. J Exp Med. 2002;196:407-412.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 30
29
34. Brown GD, Gordon S. Immune recognition. A new receptor for beta-glucans.
Nature. 2001;413:36-37.
35. Bhatnagar S, Schorey JS. Elevated mitogen-activated protein kinase signalling and
increased macrophage activation in cells infected with a glycopeptidolipid-deficient
Mycobacterium avium. Cell Micro. 2005;OnlineEarly.
36. Giaimis J, Lombard Y, Fonteneau P, et al. Both mannose and beta-glucan receptors
are involved in phagocytosis of unopsonized, heat-killed Saccharomyces cerevisiae by
murine macrophages. J Leukoc Biol. 1993;54:564-571.
37. Appelberg R, Sarmento A, Castro AG. Tumour necrosis factor-alpha (TNF-alpha)
in the host resistance to mycobacteria
of distinct virulence. Clin Exp Immunol. 1995;101:308-313.
38. Ezekowitz RA, Sastry K, Bailly P, Warner A. Molecular characterization of the
human macrophage mannose receptor: demonstration of multiple carbohydrate
recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J Exp Med.
1990;172:1785-1794.
39. Chakraborty P, Das PK. Role of mannose/N-acetylglucosamine receptors in blood
clearance and cellular attachment of Leishmania donovani. Mol Biochem Parasitol.
1988;28:55-62.
40. Ezekowitz RA, Williams DJ, Koziel H, et al. Uptake of Pneumocystis carinii
mediated by the macrophage mannose receptor. Nature. 1991;351:155-158.
41. Khoo KH, Tang JB, Chatterjee D. Variation in mannose-capped terminal arabinan
motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and
Mycobacterium avium complex. J Biol Chem. 2001;276:3863-3871.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 31
30
42. Astarie-Dequeker C, N'Diaye EN, Le Cabec V, Rittig MG, Prandi J, Maridonneau-
Parini I. The mannose receptor mediates uptake of pathogenic and nonpathogenic
mycobacteria and bypasses bactericidal responses in human macrophages. Infect Immun.
1999;67:469-477.
43. Doherty TM, Arditi M. TB, or not TB: that is the question -- does TLR signaling
hold the answer? J Clin Invest. 2004;114:1699-1703.
44. Lien E, Sellati TJ, Yoshimura A, et al. Toll-like receptor 2 functions as a pattern
recognition receptor for diverse bacterial products. J Biol Chem. 1999;274:33419-33425.
45. Jones BW, Heldwein KA, Means TK, Saukkonen JJ, Fenton MJ. Differential roles
of Toll-like receptors in the elicitation of proinflammatory responses by macrophages.
Ann Rheum Dis. 2001;60 Suppl 3:iii6-12.
46. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. Cooperation of Toll-like receptor
2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi
outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor
signaling molecules in Toll-like receptor 2 signaling. J Immunol. 2001;167:987-994.
47. Bulut Y, Michelsen KS, Hayrapetian L, et al. Mycobacterium tuberculosis heat
shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory
signals. J Biol Chem. 2005;280:20961-20967.
48. Pathak SK, Bhattacharyya A, Pathak S, et al. Toll-like receptor 2 and mitogen- and
stress-activated kinase 1 are effectors of Mycobacterium avium-induced cyclooxygenase-
2 expression in macrophages. J Biol Chem. 2004;279:55127-55136.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 32
31
49. Hajjar AM, O'Mahony DS, Ozinsky A, et al. Cutting edge: functional interactions
between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble
modulin. J Immunol. 2001;166:15-19.
50. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition
of pathogens by the innate immune system is defined by cooperation between toll-like
receptors. Proc Natl Acad Sci U S A. 2000;97:13766-13771.
51. Brown GD, Herre J, Williams DL, Willment JA, Marshall AS, Gordon S. Dectin-1
mediates the biological effects of beta-glucans. J Exp Med. 2003;197:1119-1124.
52. Rogers NC, Slack EC, Edwards AD, et al. Syk-dependent cytokine induction by
Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity.
2005;22:507-517.
53. Underhill DM, Rossnagle E, Lowell CA, Simmons RM. Dectin-1 activates Syk
tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production.
Blood. 2005.
54. Dinadayala P, Lemassu A, Granovski P, Cerantola S, Winter N, Daffe M.
Revisiting the structure of the anti-neoplastic glucans of Mycobacterium bovis Bacille
Calmette-Guerin. Structural analysis of the extracellular and boiling water extract-derived
glucans of the vaccine substrains. J Biol Chem. 2004;279:12369-12378.
55. Lemassu A, Daffe M. Structural features of the exocellular polysaccharides of
Mycobacterium tuberculosis. Biochem J. 1994;297 ( Pt 2):351-357.
56. Cywes C, Hoppe HC, Daffe M, Ehlers MR. Nonopsonic binding of Mycobacterium
tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and
is strain dependent. Infect Immun. 1997;65:4258-4266.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 33
32
57. Ariizumi K, Shen GL, Shikano S, et al. Identification of a novel, dendritic cell-
associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem.
2000;275:20157-20167.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 34
33
FIGURE LEGANDS
FIGURE 1. Mannose receptor is not essential for the phagocytosis of M. avium 724.
BMMφs from WT or MR-/- mice were infected with different ratios of complement
opsonized (A, B) or non-opsonized (C, D) mycobacteria for 1 hour (A, C) or 4 hours (B,
D). After infection, cells were washed, fixed and stained with acridine orange. The
percentage of phagocytic cells having ingested at least one Mycobacterium was measured
by fluorescence microscopy as described in Material and Methods. Values are expressed
as mean + SD. Data are representative of three separate experiments.
FIGURE 2. Mannose Receptor and Toll-like receptor 4 are not essential for MAPK
activation and TNF-α production in BMMφs upon M. smegmatis or M. avium 724
infection. BMMφs from WT and either MR-/- (A and B) or TLR4-/- (C and D) mice were
infected with M. smegmatis or M. avium 724 and screened for MAPK activation at 1 hour
and 9 hour (A and C) and TNF-α production at 24 hour (B and D). (A and C) MAPK
activation was detected by probing cell lysates of infected or non-infected (RC) BMMφs
by Western blot for activated ERK1/2 and p38 using phospho-specific Abs as described
in the Materials and Methods. Total ERK1/2 and total p38 blots were run to show equal
protein loading. (B and D) BMMφs from WT and KO mice were infected with
complement opsonized or non-opsonized mycobacteria and 24 hour later culture
supernates were removed and analyzed by ELISA for TNF-α. Values are expressed as
mean + SD. Data are representative of three separate experiments. Sm and Smeg- M.
smegmatis, Av and Avium- M. avium, RC- non-infected BMMφs.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 35
34
FIGURE 3. MyD88-/- and TLR2-/-
BMMφs show impaired MAPK activation and
TNF-α production upon mycobacterial infection. BMMφs from WT and TLR2-/- mice
(A and B) and MyD88-/- mice (C and D) were infected with M. smegmatis or M. avium
724 and screened for MAPK activation at 1 hour and 9 hour and TNF-α production at 24
h. (A and C) MAPK activation was detected by preparing cell lysates for 1 hour and 9
hour infections and probed for activated ERK1/2 and p38 using phospho-specific Abs as
described in the Materials and Methods. Total ERK1/2 and p38 blots were run to show
equal protein loading. (B and D) BMMφs from WT and KO mice were infected with
complement opsonized or non-opsonized mycobacteria and 24 hour later culture
supernates were removed and analyzed by ELISA for TNF-α. Values are expressed as
mean + SD. Data are representative of three separate experiments. Sm and Smeg- M.
smegmatis, Av and Avium- M. avium, RC- non-infected BMMφs.
FIGURE 4. Dectin-1 functions to promote TNF-α production in M. smegmatis and
M. avium 2151 infected macrophages. BMMφs were infected with (A) M. smegmatis or
M. avium 724 or M. avium 2151 in the presence of PBS or anti-Dectin mAb 2A11 or
isotype control Ab, (B) M. smegmatis in the presence of Laminarin or Galactan and (C)
complement opsonized or non-opsonized M. smegmatis in the presence of PBS, 2A11 or
isotype control Ab. Also shown is LPS treated BMMφs +/- antibodies. Culture supernates
after 24 hour infection were analyzed for TNF-α by ELISA. a, significant to M.
smegmatis plus PBS (p<0.01). b, significant to M. smegmatis alone and M. smegmatis
plus Galactan (p<0.01) Values are expressed as mean + SD. Data are representative of
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 36
35
three separate experiments. Iso-Control- Isotype control Ab, Smeg- M. smegmatis, RC-
non-infected BMMφs.
FIGURE 5. Dectin-1 mediated induction of TNF-α by BMMφs infected with M.
smegmatis requires TLR2-/-
. BMMφs from WT or TLR2-/-
mice were infected with M.
smegmatis or M. avium 724 in the presence of anti-Dectin-1 MAb 2A11. After a 4 h
infection, BMMφs were washed and fresh medium was added to the cells and infection
continued for a total of 24 h. Culture supernates were analyzed by ELISA for TNF-α. a,
significant to M. smegmatis plus PBS (p<0.01). Values are expressed as mean + SD. Data
are representative of three separate experiments. Smeg- M. smegmatis, Avium- M.
avium, RC- non-infected BMMφs.
FIGURE 6. Dectin-1 promotes TNF-α production induced in BMMφs upon
infection with non-pathogenic or attenuated mycobacteria but not H37Rv. BMMφs
were infected with M. smegmatis, M. phlei or M. bovis BCG (A) or M. tuberculosis
strains H37Rv and H37Ra (B) in the presence of anti-Dectin-1 MAb 2A11 or isotype
control Ab. After a 4 hour infection, BMMφs were washed and fresh medium was added
to the cells and the infection was continued for a total of 24 h. Culture supernates were
analyzed by ELISA for TNF-α. a, significant to mycobacteria plus PBS (p<0.01). Values
are expressed as mean + SD. Data are representative of three separate experiments.
Smeg- M. smegmatis, RC- non-infected BMMφs, Iso-Con- Isotype control Ab.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 37
36
FIGURE 7. Dectin-1 promotes IL-6, RANTES and G-CSF production in
mycobacterial infected ΒΜΜφs. Cells were infected with M. smegmatis and M. bovis
BCG (A) or M. avium 724 and M. avium 2151 (B) in the presence of PBS or anti-Dectin-
1 mAb 2A11 or isotype control Ab as described in figure 6. Culture supernatants were
analyzed for G-CSF, RANTES and IL-6 by ELISA. (B) Values are expressed as mean +
SD. Data are representative of three separate experiments. Smeg- M. smegmatis, 724- M.
avium 724, 2151- M. avium 2151, RC- non-infected BMMφs, Iso-Con- Isotype control
Ab.
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 38
37
Figure 1
0
10
20
30
40
50
% in
fect
ied
cells
WTMR-/-
01020304050607080
% in
fect
ed c
ells
WTMR-/-
-5
5
15
25
35
45
% in
fect
ed c
ells
WTMR-/-
01020304050607080
% in
fect
ed c
ells
WTMR-/-
Complement Opsonized 1 h Complement Opsonized 4 h
Non-opsonized 1 h Non-opsonized 4 h
A B
2:1 5:1 10:1 2:1 5:1 10:1
2:1 5:1 10:12:1 5:1 10:1Mycobacteria : Macrophage
Mycobacteria : Macrophage
Mycobacteria : Macrophage
Mycobacteria : Macrophage
C D
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 39
38
Figure 2
pERK1/2
Total ERK1/2
RC Sm Av Sm Av RC Sm Av Sm Av
WT MR-/-
pp38
Total p38
1 h 9 h 1 h 9 h
0500
10001500200025003000
RC Smeg Avium Smeg Avium
TNF-
α (p
g/m
)l
WTTLR4 -/-
Complement Opsonized
Non-Opsonized
B
RC Sm Av Sm Av Sm Av Sm Av RC
WT TLR4-/- KO
1 h 9 h 1 h 9 h
pERK1/2
Total ERK1/2
pp38
Total p38
A
DC
Complement Opsonized
Non-Opsonized
0
500
1000
1500
2000
RC Smeg Avium Smeg Avium
TNF-
α (p
g/m
l)
WTMR-/- KO
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 40
39
Figure 3
0500
1000150020002500
R C Smeg A vium Smeg A vium
TNF-
α (p
g/m
l)
BL/6 WT
MyD88-/-
0500
10001500200025003000
R C Smeg A vium Smeg A vium
TNF-
α (p
g/m
l)
WTTLR2-/-
pp38
pERK1/2
Total ERK1/2
RC Sm A v RC Sm Av RC Sm Av RC Sm Av
9 hours
WT TLR2-/-WT TLR2-/-
1 hour
pp38
pERK1/2
Total ERK1/2
RC Sm Av RC Sm Av RC Sm Av RC Sm Av
9 hours
WT MyD88-/-WT MyD88 -/-
1 hour
Complement Opsonized
Non-Opsonized
A
D
B
C
Complement Opsonized
Non-Opsonized
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 41
40
Figure 4
0
500
1000
1500
2000
2500
RC RC Smeg Sm eg Smeg
TNF-
α (p
g/m
l)
Laminarin ─ + ─ + ─ Galactan ─ ─ ─ ─ +
A B
b
0500
1000150020002500300035004000
RC Smeg Smeg LPS
TNF-
α (p
g/m
l)
PBS2A11Iso-Con
Opsonized Non-Opsonized
C
a
a
0200400600800
10001200140016001800
RC Smeg 724 2151
TNF-
α (p
g/m
l)
PBS2A11Iso-Con
a a
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 42
41
Figure 5
0200400600800
10001200140016001800
RC Smeg Avium RC Smeg Avium
TNF-
α (p
g/m
l)
PBS2A11
WT TLR2-/-
a
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 43
42
Figure 6
0200400600800
10001200140016001800
RC Smeg Phlei BCG
TNF-
α (p
g/m
l)
PBS2A11Iso-Con
aa
a
A
B
a
050
100150200250300350400450500
RC H37Ra H37Rv
TNF-
α (p
g/m
l)
PBS2A11Iso-Control
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom
Page 44
43
Figure 7
0
5 0 0
1 0 0 0
1 5 0 0
P B S2A11Iso -C o n tro l3 5 0 0
4 0 0 04 5 0 05 0 0 0
pg/m
l
----RC--- ---SMEG--- ----BCG---- ---RC--- ----SMEG--- ----BCG---- ----RC---- ----SMEG--- ----BCG----
---------------IL-6----------------- ------------RANTES------------ -------------G-CSF---------------
0
5 0 0
1 0 0 0
1 5 0 0
P B S2A11Iso -C o n tro l3 5 0 0
4 0 0 04 5 0 05 0 0 0
pg/m
l
----RC--- ---SMEG--- ----BCG---- ---RC--- ----SMEG--- ----BCG---- ----RC---- ----SMEG--- ----BCG----
---------------IL-6----------------- ------------RANTES------------ -------------G-CSF---------------
----RC----- -----724---- -----2151---- ----RC----- -----724----- ----2151---- ----RC---- -----724----- ----2151----0
5 0 0
1 0 0 0
2 0 0 0
2 5 0 0
3 0 0 0
3 5 0 0P B S2 A1 1Is o -C o n tro l
pg/m
l
---------------IL-6----------------- ------------RANTES------------ -------------G-CSF-------------------RC----- -----724---- -----2151---- ----RC----- -----724----- ----2151---- ----RC---- -----724----- ----2151----
0
5 0 0
1 0 0 0
2 0 0 0
2 5 0 0
3 0 0 0
3 5 0 0P B S2 A1 1Is o -C o n tro l
pg/m
l
---------------IL-6----------------- ------------RANTES------------ -------------G-CSF---------------
A
B
a
a
a
a
aa
a
a
a a
For personal use only. by guest on January 12, 2014. bloodjournal.hematologylibrary.orgFrom